Allovir
Get Full AccessDescription
- AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The companys technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. AlloVirs technology and manufacturing process enables the potential for the treatment and/or prevention of up to six devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
-
Headquarters:139 Main Street , Cambridge, Massachusetts, United States
More -
Phone Number: +1 617-433-2605
-
Website: http://www.allovir.com
-
Employees:53
-
Revenue:$50 - 100M
-
Legal Name:Allovir
-
Allovir's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Allovir
-
Where are Allovir's Headquarters?
Allovir's Headquarters are in 139 Main Street ,Cambridge,Massachusetts,United States
-
What is Allovir's phone number?
Allovir's phone number is +1 617-433-2605
-
What is Allovir's official website?
Allovir's official website is http://www.allovir.com
-
What is Allovir's Revenue?
Allovir's revenue is $50 - 100M
-
What is Allovir's NAICS code?
Allovir's NAICS code is 541713
-
How many employees are working in Allovir
Allovir has 53 employees
-
What is Allovir's Industry?
Allovir is in the industry of Biotechnology
-
Who is Allovir's CEO?
Allovir's CEO is Diana Brainard